CIK 0001281895 · Non-accelerated filer<br>Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- 4 Open-market sale CEO sold 2,409 shares at $3.01 ($7,261)
- 4 Open-market sale General Counsel sold 662 shares at $3.01 ($1,995)
- 4 Open-market sale See Remarks sold 384 shares at $3.01 ($1,157)
- 4 Open-market sale General Counsel sold 3,361 shares at $3.61 ($12,120)
- 4 Open-market sale CEO sold 2,728 shares at $3.61 ($9,837)
- 4 Open-market sale See Remarks sold 855 shares at $3.61 ($3,083)
- 4 Open-market sale See Remarks sold 17,650 shares at $3.84 ($67,741)
- 4 Open-market sale See Remarks sold 1,157 shares at $3.34 ($3,862)
- 4 Open-market sale CEO sold 5,990 shares at $3.34 ($19,995)
- 4 Open-market sale General Counsel sold 1,376 shares at $3.34 ($4,593)
- 4 Open-market sale General Counsel sold 12,253 shares at $3.31 ($40,582)
- 4 Open-market sale See Remarks sold 3,726 shares at $3.31 ($12,341)
- 4 Open-market sale CEO sold 12,279 shares at $3.31 ($40,668)
- 4 Grant or award CEO acquired 286,028 shares (grant or award)
- 4 Grant or award See Remarks acquired 29,982 shares (grant or award)
- 4 Grant or award General Counsel acquired 311,813 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 61,963 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 61,963 shares (grant or award)
- 4 Grant or award See Remarks acquired 125,924 shares (grant or award)
- 4 Open-market buy Director bought 10,000 shares at $3.44 ($34,400)
Page 2 of 21 · 406 filings